Cargando…
Pathways to COVID-19 ‘community protection’
To date, no country has reached a natural COVID-19 epidemic peak and observed peaks essentially reflect the effectiveness of ‘lockdown’ measures. The major challenge is finding a responsible way out of ‘lockdown’, given that SARS- CoV-2 is now an established global pathogen. Acknowledging limitation...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233221/ https://www.ncbi.nlm.nih.gov/pubmed/32425642 http://dx.doi.org/10.1016/j.ijid.2020.05.058 |
_version_ | 1783535506801295360 |
---|---|
author | Marais, B.J. Sorrell, T.C. |
author_facet | Marais, B.J. Sorrell, T.C. |
author_sort | Marais, B.J. |
collection | PubMed |
description | To date, no country has reached a natural COVID-19 epidemic peak and observed peaks essentially reflect the effectiveness of ‘lockdown’ measures. The major challenge is finding a responsible way out of ‘lockdown’, given that SARS- CoV-2 is now an established global pathogen. Acknowledging limitations in our knowledge regarding the sufficiency and durability of immune responses following natural SARS Cov-2 infection, we discuss three pathways to ‘community protection’. Uncontrolled epidemic spread (route 1; R(0) > 2) has been associated with overwhelmed health care systems and high death rates, especially in the vulnerable. Controlled epidemic spread (route 2; effective R(0) 1–2) can be achieved with limited or strict control of social mixing; strict control will be necessary to ensure that only low-risk individuals become infected, without spill-over to vulnerable groups during their period of infectiousness. It has been demonstrated that local epidemic elimination (route 3; effective R(0) < 1) can be achieved through prolonged ‘lock down’, supplemented by early active case finding with quarantine of close contacts to ensure rapid termination of transmission chains within the community. Although universal availability of a safe and effective vaccine remains the preferred ‘exit strategy’, this may be hard to achieve and alternative options must be considered with careful consideration of all adverse outcomes – including health, social and economic consequences. |
format | Online Article Text |
id | pubmed-7233221 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72332212020-05-18 Pathways to COVID-19 ‘community protection’ Marais, B.J. Sorrell, T.C. Int J Infect Dis Perspective To date, no country has reached a natural COVID-19 epidemic peak and observed peaks essentially reflect the effectiveness of ‘lockdown’ measures. The major challenge is finding a responsible way out of ‘lockdown’, given that SARS- CoV-2 is now an established global pathogen. Acknowledging limitations in our knowledge regarding the sufficiency and durability of immune responses following natural SARS Cov-2 infection, we discuss three pathways to ‘community protection’. Uncontrolled epidemic spread (route 1; R(0) > 2) has been associated with overwhelmed health care systems and high death rates, especially in the vulnerable. Controlled epidemic spread (route 2; effective R(0) 1–2) can be achieved with limited or strict control of social mixing; strict control will be necessary to ensure that only low-risk individuals become infected, without spill-over to vulnerable groups during their period of infectiousness. It has been demonstrated that local epidemic elimination (route 3; effective R(0) < 1) can be achieved through prolonged ‘lock down’, supplemented by early active case finding with quarantine of close contacts to ensure rapid termination of transmission chains within the community. Although universal availability of a safe and effective vaccine remains the preferred ‘exit strategy’, this may be hard to achieve and alternative options must be considered with careful consideration of all adverse outcomes – including health, social and economic consequences. The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2020-07 2020-05-18 /pmc/articles/PMC7233221/ /pubmed/32425642 http://dx.doi.org/10.1016/j.ijid.2020.05.058 Text en © 2020 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Perspective Marais, B.J. Sorrell, T.C. Pathways to COVID-19 ‘community protection’ |
title | Pathways to COVID-19 ‘community protection’ |
title_full | Pathways to COVID-19 ‘community protection’ |
title_fullStr | Pathways to COVID-19 ‘community protection’ |
title_full_unstemmed | Pathways to COVID-19 ‘community protection’ |
title_short | Pathways to COVID-19 ‘community protection’ |
title_sort | pathways to covid-19 ‘community protection’ |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233221/ https://www.ncbi.nlm.nih.gov/pubmed/32425642 http://dx.doi.org/10.1016/j.ijid.2020.05.058 |
work_keys_str_mv | AT maraisbj pathwaystocovid19communityprotection AT sorrelltc pathwaystocovid19communityprotection |